Align Technology, Inc. (NASDAQ:ALGN) Shares Acquired by Schaper Benz & Wise Investment Counsel Inc. WI

Schaper Benz & Wise Investment Counsel Inc. WI increased its position in Align Technology, Inc. (NASDAQ:ALGN) by 2.2% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 39,265 shares of the medical equipment provider’s stock after buying an additional 856 shares during the period. Schaper Benz & Wise Investment Counsel Inc. WI owned about 0.05% of Align Technology worth $9,986,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Mather Group LLC. purchased a new stake in shares of Align Technology during the 1st quarter valued at about $26,000. LRI Investments LLC bought a new position in Align Technology in the 1st quarter worth approximately $29,000. Cullen Frost Bankers Inc. increased its holdings in shares of Align Technology by 854.5% during the second quarter. Cullen Frost Bankers Inc. now owns 105 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 94 shares during the period. Rothschild Investment LLC bought a new stake in Align Technology during the second quarter worth approximately $26,000. Finally, Innealta Capital LLC bought a new stake in shares of Align Technology in the 2nd quarter worth approximately $26,000. Hedge funds and other institutional investors own 88.43% of the company’s stock.

Insider Buying and Selling

In other Align Technology news, Director C Raymond Larkin, Jr. bought 6,500 shares of the business’s stock in a transaction on Thursday, August 15th. The shares were bought at an average cost of $235.33 per share, for a total transaction of $1,529,645.00. Following the transaction, the director now owns 28,247 shares in the company, valued at approximately $6,647,366.51. This trade represents a 0.00 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Corporate insiders own 0.62% of the company’s stock.

Align Technology Stock Performance

Align Technology stock opened at $219.70 on Friday. Align Technology, Inc. has a 52 week low of $176.34 and a 52 week high of $335.40. The firm has a market cap of $16.54 billion, a P/E ratio of 36.19, a P/E/G ratio of 5.33 and a beta of 1.64. The business’s fifty day moving average is $234.57 and its two-hundred day moving average is $253.11.

Align Technology (NASDAQ:ALGN) last posted its quarterly earnings data on Wednesday, July 24th. The medical equipment provider reported $2.41 earnings per share for the quarter, topping the consensus estimate of $2.32 by $0.09. The firm had revenue of $1.03 billion during the quarter, compared to analysts’ expectations of $1.04 billion. Align Technology had a net margin of 11.34% and a return on equity of 14.07%. Align Technology’s revenue was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.73 EPS. On average, equities research analysts predict that Align Technology, Inc. will post 7.61 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Several research analysts have recently weighed in on the stock. Piper Sandler dropped their target price on shares of Align Technology from $315.00 to $285.00 and set an “overweight” rating on the stock in a research report on Thursday. Morgan Stanley cut their target price on Align Technology from $328.00 to $310.00 and set an “overweight” rating on the stock in a report on Thursday, July 25th. Needham & Company LLC assumed coverage on shares of Align Technology in a report on Thursday, October 10th. They set a “hold” rating for the company. Evercore ISI dropped their price target on Align Technology from $280.00 to $270.00 and set an “outperform” rating on the stock in a research report on Tuesday, October 8th. Finally, StockNews.com upgraded shares of Align Technology from a “hold” rating to a “buy” rating in a research note on Thursday, September 19th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $291.25.

Align Technology Company Profile

Align Technology, Inc designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth.